JNNP:一项发育障碍——C9orf72突变基因携带者的口语流利性不足

2020-09-02 MedSci原创 MedSci原创

C9orf72中基因的突变使得肌萎缩性侧索硬化症(ALS)和额颞痴呆(FTD)之间发生了交联。在临床表现上,两种疾病都有可能表现出行为,语言障碍(FTD中)或运动功能障碍(在ALS中)。

C9orf72中基因的突变使得肌萎缩性侧索硬化症(ALS)和额颞痴呆(FTD)之间发生了交联。在临床表现上,两种疾病都有可能表现出行为,语言障碍(FTD中)或运动功能障碍(在ALS中)。这项ALS研究包括常规的生物标志物,影像学,临床和神经心理学测试。

方法:总共检查了36个来自ALS或FTD家族的无症状C9orf72基因突变携带者,包括21名具有C9orf72基因突变的受试者和15名具有SOD1突变的受试者。将数据与91位年龄相匹配,受教育程度相匹配和性别相匹配的健康受试者(56位来自ALS或FTD家庭的一级亲属,35位没有ALS / FTD家族史的人)进行了比较。进行MRI弥散张量成像扫描以绘制分数各向异性(FA)。受试者进行了广泛的神经心理学评估,以解决语言的流利性,语言,执行力,记忆力和视觉空间功能。 12个月后进行重复测量。

结果:与SOD1突变或健康受试者相比,C9orf72基因突变携带者的口语流利性和非语言记忆能力明显更差,并且在结构白质完整性方面表现出明显变化,下部和眶额皮质区域的FA值较低。结构完整性的丧失与口语流利性的下降有关。在所有受试者中,白质变化和认知能力在12个月内均未见变化。

讨论:言语流畅性下降似乎是有症状发作前C9orf72携带者的一项独特临床特征,在研究中没有发现随时间变化的证据。这些结果支持了除了C9orf72携带者的神经变性外,还出现了一般发育障碍的新理论。

原文链接:Lulé DEMüller HFinsel J, et al Deficits in verbal fluency in presymptomatic C9orf72 mutation gene carriers—a developmental disorder

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2004939, encodeId=005b20049394a, content=<a href='/topic/show?id=2f48569264d' target=_blank style='color:#2F92EE;'>#携带者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56926, encryptionId=2f48569264d, topicName=携带者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=640c454, createdName=qblt, createdTime=Mon Mar 22 23:32:18 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044921, encodeId=4c94204492100, content=<a href='/topic/show?id=32053926d2' target=_blank style='color:#2F92EE;'>#C9orf72突变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3926, encryptionId=32053926d2, topicName=C9orf72突变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Fri Jan 01 10:32:18 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060821, encodeId=80962060821e2, content=<a href='/topic/show?id=c73f3e96355' target=_blank style='color:#2F92EE;'>#发育障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37963, encryptionId=c73f3e96355, topicName=发育障碍)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295c372, createdName=chaojitidian, createdTime=Wed Mar 10 07:32:18 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347504, encodeId=1a0c134e5044d, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Fri Sep 04 14:32:18 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426292, encodeId=76f7142629208, content=<a href='/topic/show?id=0eba392457' target=_blank style='color:#2F92EE;'>#C9orf72#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3924, encryptionId=0eba392457, topicName=C9orf72)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=683d4051559, createdName=cmsvly, createdTime=Fri Sep 04 14:32:18 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618084, encodeId=72e91618084da, content=<a href='/topic/show?id=4271e550237' target=_blank style='color:#2F92EE;'>#突变基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75502, encryptionId=4271e550237, topicName=突变基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bf319833427, createdName=ms1490123962508630, createdTime=Fri Sep 04 14:32:18 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882348, encodeId=a8768823483b, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Sep 03 08:10:46 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882297, encodeId=c69e88229e1b, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200802/2d1be4b00f2042fdb7133156db033753/68b000cd6c2e409688928b278fd0eebb.jpg, createdBy=4e205263076, createdName=Super骨科赵, createdTime=Wed Sep 02 23:59:25 CST 2020, time=2020-09-02, status=1, ipAttribution=)]
    2021-03-22 qblt
  2. [GetPortalCommentsPageByObjectIdResponse(id=2004939, encodeId=005b20049394a, content=<a href='/topic/show?id=2f48569264d' target=_blank style='color:#2F92EE;'>#携带者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56926, encryptionId=2f48569264d, topicName=携带者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=640c454, createdName=qblt, createdTime=Mon Mar 22 23:32:18 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044921, encodeId=4c94204492100, content=<a href='/topic/show?id=32053926d2' target=_blank style='color:#2F92EE;'>#C9orf72突变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3926, encryptionId=32053926d2, topicName=C9orf72突变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Fri Jan 01 10:32:18 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060821, encodeId=80962060821e2, content=<a href='/topic/show?id=c73f3e96355' target=_blank style='color:#2F92EE;'>#发育障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37963, encryptionId=c73f3e96355, topicName=发育障碍)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295c372, createdName=chaojitidian, createdTime=Wed Mar 10 07:32:18 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347504, encodeId=1a0c134e5044d, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Fri Sep 04 14:32:18 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426292, encodeId=76f7142629208, content=<a href='/topic/show?id=0eba392457' target=_blank style='color:#2F92EE;'>#C9orf72#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3924, encryptionId=0eba392457, topicName=C9orf72)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=683d4051559, createdName=cmsvly, createdTime=Fri Sep 04 14:32:18 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618084, encodeId=72e91618084da, content=<a href='/topic/show?id=4271e550237' target=_blank style='color:#2F92EE;'>#突变基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75502, encryptionId=4271e550237, topicName=突变基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bf319833427, createdName=ms1490123962508630, createdTime=Fri Sep 04 14:32:18 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882348, encodeId=a8768823483b, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Sep 03 08:10:46 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882297, encodeId=c69e88229e1b, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200802/2d1be4b00f2042fdb7133156db033753/68b000cd6c2e409688928b278fd0eebb.jpg, createdBy=4e205263076, createdName=Super骨科赵, createdTime=Wed Sep 02 23:59:25 CST 2020, time=2020-09-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2004939, encodeId=005b20049394a, content=<a href='/topic/show?id=2f48569264d' target=_blank style='color:#2F92EE;'>#携带者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56926, encryptionId=2f48569264d, topicName=携带者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=640c454, createdName=qblt, createdTime=Mon Mar 22 23:32:18 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044921, encodeId=4c94204492100, content=<a href='/topic/show?id=32053926d2' target=_blank style='color:#2F92EE;'>#C9orf72突变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3926, encryptionId=32053926d2, topicName=C9orf72突变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Fri Jan 01 10:32:18 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060821, encodeId=80962060821e2, content=<a href='/topic/show?id=c73f3e96355' target=_blank style='color:#2F92EE;'>#发育障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37963, encryptionId=c73f3e96355, topicName=发育障碍)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295c372, createdName=chaojitidian, createdTime=Wed Mar 10 07:32:18 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347504, encodeId=1a0c134e5044d, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Fri Sep 04 14:32:18 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426292, encodeId=76f7142629208, content=<a href='/topic/show?id=0eba392457' target=_blank style='color:#2F92EE;'>#C9orf72#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3924, encryptionId=0eba392457, topicName=C9orf72)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=683d4051559, createdName=cmsvly, createdTime=Fri Sep 04 14:32:18 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618084, encodeId=72e91618084da, content=<a href='/topic/show?id=4271e550237' target=_blank style='color:#2F92EE;'>#突变基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75502, encryptionId=4271e550237, topicName=突变基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bf319833427, createdName=ms1490123962508630, createdTime=Fri Sep 04 14:32:18 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882348, encodeId=a8768823483b, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Sep 03 08:10:46 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882297, encodeId=c69e88229e1b, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200802/2d1be4b00f2042fdb7133156db033753/68b000cd6c2e409688928b278fd0eebb.jpg, createdBy=4e205263076, createdName=Super骨科赵, createdTime=Wed Sep 02 23:59:25 CST 2020, time=2020-09-02, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2004939, encodeId=005b20049394a, content=<a href='/topic/show?id=2f48569264d' target=_blank style='color:#2F92EE;'>#携带者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56926, encryptionId=2f48569264d, topicName=携带者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=640c454, createdName=qblt, createdTime=Mon Mar 22 23:32:18 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044921, encodeId=4c94204492100, content=<a href='/topic/show?id=32053926d2' target=_blank style='color:#2F92EE;'>#C9orf72突变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3926, encryptionId=32053926d2, topicName=C9orf72突变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Fri Jan 01 10:32:18 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060821, encodeId=80962060821e2, content=<a href='/topic/show?id=c73f3e96355' target=_blank style='color:#2F92EE;'>#发育障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37963, encryptionId=c73f3e96355, topicName=发育障碍)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295c372, createdName=chaojitidian, createdTime=Wed Mar 10 07:32:18 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347504, encodeId=1a0c134e5044d, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Fri Sep 04 14:32:18 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426292, encodeId=76f7142629208, content=<a href='/topic/show?id=0eba392457' target=_blank style='color:#2F92EE;'>#C9orf72#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3924, encryptionId=0eba392457, topicName=C9orf72)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=683d4051559, createdName=cmsvly, createdTime=Fri Sep 04 14:32:18 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618084, encodeId=72e91618084da, content=<a href='/topic/show?id=4271e550237' target=_blank style='color:#2F92EE;'>#突变基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75502, encryptionId=4271e550237, topicName=突变基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bf319833427, createdName=ms1490123962508630, createdTime=Fri Sep 04 14:32:18 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882348, encodeId=a8768823483b, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Sep 03 08:10:46 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882297, encodeId=c69e88229e1b, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200802/2d1be4b00f2042fdb7133156db033753/68b000cd6c2e409688928b278fd0eebb.jpg, createdBy=4e205263076, createdName=Super骨科赵, createdTime=Wed Sep 02 23:59:25 CST 2020, time=2020-09-02, status=1, ipAttribution=)]
    2020-09-04 neurowu
  5. [GetPortalCommentsPageByObjectIdResponse(id=2004939, encodeId=005b20049394a, content=<a href='/topic/show?id=2f48569264d' target=_blank style='color:#2F92EE;'>#携带者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56926, encryptionId=2f48569264d, topicName=携带者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=640c454, createdName=qblt, createdTime=Mon Mar 22 23:32:18 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044921, encodeId=4c94204492100, content=<a href='/topic/show?id=32053926d2' target=_blank style='color:#2F92EE;'>#C9orf72突变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3926, encryptionId=32053926d2, topicName=C9orf72突变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Fri Jan 01 10:32:18 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060821, encodeId=80962060821e2, content=<a href='/topic/show?id=c73f3e96355' target=_blank style='color:#2F92EE;'>#发育障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37963, encryptionId=c73f3e96355, topicName=发育障碍)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295c372, createdName=chaojitidian, createdTime=Wed Mar 10 07:32:18 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347504, encodeId=1a0c134e5044d, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Fri Sep 04 14:32:18 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426292, encodeId=76f7142629208, content=<a href='/topic/show?id=0eba392457' target=_blank style='color:#2F92EE;'>#C9orf72#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3924, encryptionId=0eba392457, topicName=C9orf72)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=683d4051559, createdName=cmsvly, createdTime=Fri Sep 04 14:32:18 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618084, encodeId=72e91618084da, content=<a href='/topic/show?id=4271e550237' target=_blank style='color:#2F92EE;'>#突变基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75502, encryptionId=4271e550237, topicName=突变基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bf319833427, createdName=ms1490123962508630, createdTime=Fri Sep 04 14:32:18 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882348, encodeId=a8768823483b, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Sep 03 08:10:46 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882297, encodeId=c69e88229e1b, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200802/2d1be4b00f2042fdb7133156db033753/68b000cd6c2e409688928b278fd0eebb.jpg, createdBy=4e205263076, createdName=Super骨科赵, createdTime=Wed Sep 02 23:59:25 CST 2020, time=2020-09-02, status=1, ipAttribution=)]
    2020-09-04 cmsvly
  6. [GetPortalCommentsPageByObjectIdResponse(id=2004939, encodeId=005b20049394a, content=<a href='/topic/show?id=2f48569264d' target=_blank style='color:#2F92EE;'>#携带者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56926, encryptionId=2f48569264d, topicName=携带者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=640c454, createdName=qblt, createdTime=Mon Mar 22 23:32:18 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044921, encodeId=4c94204492100, content=<a href='/topic/show?id=32053926d2' target=_blank style='color:#2F92EE;'>#C9orf72突变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3926, encryptionId=32053926d2, topicName=C9orf72突变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Fri Jan 01 10:32:18 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060821, encodeId=80962060821e2, content=<a href='/topic/show?id=c73f3e96355' target=_blank style='color:#2F92EE;'>#发育障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37963, encryptionId=c73f3e96355, topicName=发育障碍)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295c372, createdName=chaojitidian, createdTime=Wed Mar 10 07:32:18 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347504, encodeId=1a0c134e5044d, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Fri Sep 04 14:32:18 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426292, encodeId=76f7142629208, content=<a href='/topic/show?id=0eba392457' target=_blank style='color:#2F92EE;'>#C9orf72#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3924, encryptionId=0eba392457, topicName=C9orf72)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=683d4051559, createdName=cmsvly, createdTime=Fri Sep 04 14:32:18 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618084, encodeId=72e91618084da, content=<a href='/topic/show?id=4271e550237' target=_blank style='color:#2F92EE;'>#突变基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75502, encryptionId=4271e550237, topicName=突变基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bf319833427, createdName=ms1490123962508630, createdTime=Fri Sep 04 14:32:18 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882348, encodeId=a8768823483b, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Sep 03 08:10:46 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882297, encodeId=c69e88229e1b, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200802/2d1be4b00f2042fdb7133156db033753/68b000cd6c2e409688928b278fd0eebb.jpg, createdBy=4e205263076, createdName=Super骨科赵, createdTime=Wed Sep 02 23:59:25 CST 2020, time=2020-09-02, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=2004939, encodeId=005b20049394a, content=<a href='/topic/show?id=2f48569264d' target=_blank style='color:#2F92EE;'>#携带者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56926, encryptionId=2f48569264d, topicName=携带者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=640c454, createdName=qblt, createdTime=Mon Mar 22 23:32:18 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044921, encodeId=4c94204492100, content=<a href='/topic/show?id=32053926d2' target=_blank style='color:#2F92EE;'>#C9orf72突变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3926, encryptionId=32053926d2, topicName=C9orf72突变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Fri Jan 01 10:32:18 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060821, encodeId=80962060821e2, content=<a href='/topic/show?id=c73f3e96355' target=_blank style='color:#2F92EE;'>#发育障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37963, encryptionId=c73f3e96355, topicName=发育障碍)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295c372, createdName=chaojitidian, createdTime=Wed Mar 10 07:32:18 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347504, encodeId=1a0c134e5044d, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Fri Sep 04 14:32:18 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426292, encodeId=76f7142629208, content=<a href='/topic/show?id=0eba392457' target=_blank style='color:#2F92EE;'>#C9orf72#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3924, encryptionId=0eba392457, topicName=C9orf72)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=683d4051559, createdName=cmsvly, createdTime=Fri Sep 04 14:32:18 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618084, encodeId=72e91618084da, content=<a href='/topic/show?id=4271e550237' target=_blank style='color:#2F92EE;'>#突变基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75502, encryptionId=4271e550237, topicName=突变基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bf319833427, createdName=ms1490123962508630, createdTime=Fri Sep 04 14:32:18 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882348, encodeId=a8768823483b, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Sep 03 08:10:46 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882297, encodeId=c69e88229e1b, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200802/2d1be4b00f2042fdb7133156db033753/68b000cd6c2e409688928b278fd0eebb.jpg, createdBy=4e205263076, createdName=Super骨科赵, createdTime=Wed Sep 02 23:59:25 CST 2020, time=2020-09-02, status=1, ipAttribution=)]
    2020-09-03 14818eb4m67暂无昵称

    学习

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2004939, encodeId=005b20049394a, content=<a href='/topic/show?id=2f48569264d' target=_blank style='color:#2F92EE;'>#携带者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56926, encryptionId=2f48569264d, topicName=携带者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=640c454, createdName=qblt, createdTime=Mon Mar 22 23:32:18 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044921, encodeId=4c94204492100, content=<a href='/topic/show?id=32053926d2' target=_blank style='color:#2F92EE;'>#C9orf72突变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3926, encryptionId=32053926d2, topicName=C9orf72突变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Fri Jan 01 10:32:18 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060821, encodeId=80962060821e2, content=<a href='/topic/show?id=c73f3e96355' target=_blank style='color:#2F92EE;'>#发育障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37963, encryptionId=c73f3e96355, topicName=发育障碍)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295c372, createdName=chaojitidian, createdTime=Wed Mar 10 07:32:18 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347504, encodeId=1a0c134e5044d, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Fri Sep 04 14:32:18 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426292, encodeId=76f7142629208, content=<a href='/topic/show?id=0eba392457' target=_blank style='color:#2F92EE;'>#C9orf72#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3924, encryptionId=0eba392457, topicName=C9orf72)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=683d4051559, createdName=cmsvly, createdTime=Fri Sep 04 14:32:18 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618084, encodeId=72e91618084da, content=<a href='/topic/show?id=4271e550237' target=_blank style='color:#2F92EE;'>#突变基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75502, encryptionId=4271e550237, topicName=突变基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bf319833427, createdName=ms1490123962508630, createdTime=Fri Sep 04 14:32:18 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882348, encodeId=a8768823483b, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Sep 03 08:10:46 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882297, encodeId=c69e88229e1b, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200802/2d1be4b00f2042fdb7133156db033753/68b000cd6c2e409688928b278fd0eebb.jpg, createdBy=4e205263076, createdName=Super骨科赵, createdTime=Wed Sep 02 23:59:25 CST 2020, time=2020-09-02, status=1, ipAttribution=)]
    2020-09-02 Super骨科赵

    学习

    0

相关资讯

Nature :肠道环境“赐予”p53基因的两面派作用:抗癌or促癌

与小肠比,结肠为什么这么容易产生癌变?研究团队在研究肠道细菌与胃肠道癌的联系时发现,癌症突变本身并不一定是有害的。事实上,在某些肠道微环境中,这些突变实际上可以帮助机体对抗癌症,而不是使癌症扩散。

Nature│研究揭示基因与自闭症的新联系,为拯救自闭症、恢复其社会行为带来新希望

所有的孩子都生活在同一片天空下,但不是所有的孩子脸上都洋溢着天真的笑容。

Cell Res :复旦大学发布三阴性乳腺癌精准治疗方案,让患者从山穷水尽到柳暗花明

三阴性乳腺癌是所有乳腺癌中的一种,因雌激素受体、孕激素受体和HER-2三个主要治疗靶点均为阴性而被称为“三阴”,约占所有乳腺癌的15%左右。这种乳腺癌由于缺乏靶点、复发转移风险高,被认为最毒、最凶险。

JAMA:来自两对重症兄弟的洞见,这个基因对抵御新冠病毒很重要

《美国医学会杂志》(JAMA)近日发表一项来自荷兰团队的研究,对两对年轻兄弟重症患者的分析提示,TLR7基因在人体对新冠病毒的免疫应答中扮演了重要角色。进一步理解和治疗新冠病毒疾病提供了重要洞见。

Nat BME:基于Cas13的SARS-CoV-2RNA检测方法的临床验证

由SARS-CoV-2病毒的传播引起的COVID-19大流行需要快速、敏感和廉价的诊断方法来促进疾病的控制。实时定量PCR和逆转录(RT-qPCR)测量病毒RNA的数量,仍然是SARS-CoV-2病毒

Oncogene:MYC下调MEIS1介导前列腺癌的发展

在大多数男性中,局部前列腺癌发展非常缓慢。雄激素受体(AR)和MYC转录因子是前列腺癌致瘤中最为明确的驱使因子。腔内前列腺癌细胞中MYC的上调与AR的终端分化作用相反。然而,MYC上调的作用具有多效性